Delivery Order SPE2DB25D3017-SPE2DB25FVKAW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,675.75 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a firm fixed price and an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract was issued on July 25, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packages of 30, with a ceiling value of $5,627.91. This is a firm fixed-price delivery order contract with an ultimate completion date of July 21, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,007.04 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packages of 30 units. This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $14,672.56 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). The contract is structured as a firm fixed price delivery order with a completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitively awarded contract. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,137.56 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on July 22, 2025, with a ceiling value of $3,018.90 and an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 25, 2025, procures Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30 count) for the Defense Logistics Agency (DLA) at a firm fixed price of $1,243.56. The contract is not set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. Performance will be completed by July 28, 2025, with delivery to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,160.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,015,334 units of Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. This delivery order contract has a period of performance through March 20, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp serves as the prime contractor and holds an indefinite delivery contract...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKAWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,086.20 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. Through its DLA prime vendor contract, the company supplies an extensive portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This particular delivery order for an antihypertensive medication reflects the company's ongoing role in fulfilling routine pharmaceutical supply needs within the broader military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/30/25 |